Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Normal Renal Function”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06547502
What this trial is testing

Pharmacokinetics and Safety Profile of a Single Dose GZR4 in Subjects with Renal Impairment

Who this might be right for
Diabetes
Gan and Lee Pharmaceuticals, USA 16
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Early research (Phase 1)Study completedNCT00824590
What this trial is testing

A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function

Who this might be right for
Alzheimer's DiseaseHuntington's Disease
Pfizer 20
Early research (Phase 1)Study completedNCT00750620
What this trial is testing

A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Astellas Pharma Inc 33
Early research (Phase 1)Study completedNCT05515458
What this trial is testing

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Chipscreen Biosciences, Ltd. 24
Early research (Phase 1)Study completedNCT06397872
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Madrigal Pharmaceuticals, Inc. 28
Early research (Phase 1)Study completedNCT02775955
What this trial is testing

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

Who this might be right for
Healthy
Pharmaceutical Project Solutions, Inc. 24
Not applicableUnknownNCT05418946
What this trial is testing

The Effects of Dapagliflozin in Normal Clinical Practice in T2D

Who this might be right for
Type 2 Diabetes
University of Milan 1,400
Early research (Phase 1)Study completedNCT02634437
What this trial is testing

Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects

Who this might be right for
Renal Function
Allergan 19
Early research (Phase 1)Study completedNCT02965040
What this trial is testing

Roxadustat in Subjects With Different Degrees of Renal Function

Who this might be right for
Normal Renal FunctionImpaired Renal Function
Astellas Pharma Europe B.V. 34
Early research (Phase 1)Study completedNCT04565171
What this trial is testing

Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD

Who this might be right for
Renal Impairment
Sunshine Lake Pharma Co., Ltd. 16
Early research (Phase 1)Study completedNCT03605277
What this trial is testing

Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 14
Early research (Phase 1)Study completedNCT01763190
What this trial is testing

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

Who this might be right for
Renal Impairment
Bristol-Myers Squibb 36
Early research (Phase 1)Study completedNCT07551570
What this trial is testing

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Who this might be right for
Renal Impairment
Jiangsu vcare pharmaceutical technology co., LTD 32
Large-scale testing (Phase 3)Study completedNCT00482599
What this trial is testing

Efficacy, Pharmacokinetics and Safety of Org 25969 in Subjects With Normal or Impaired Renal Function (19.4.304)(P05948)(COMPLETED)

Who this might be right for
Anesthesia, General
Merck Sharp & Dohme LLC 30
Early research (Phase 1)Study completedNCT01730469
What this trial is testing

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

Who this might be right for
Fabry Disease
Amicus Therapeutics 32
Early research (Phase 1)Study completedNCT04656795
What this trial is testing

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

Who this might be right for
Renal ImpairmentNormal Renal Function
Tanabe Pharma America, Inc. 32
Early research (Phase 1)Study completedNCT02441829
What this trial is testing

Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function

Who this might be right for
Long QT Syndrome
Gilead Sciences 55
Early research (Phase 1)Study completedNCT01240967
What this trial is testing

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Who this might be right for
Healthy VolunteersPatientsPharmacokinetics+1 more
AstraZeneca 40
Early research (Phase 1)Study completedNCT06698549
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Who this might be right for
COVID 19
Aligos Therapeutics 12
Next Page